Cosentyx

(secukinumab)
0.5 ML secukinumab 150 MG/ML Prefilled Syringe [Cosentyx]1 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx]
View 1 more
NO BLACK BOX WARNING

Dosage & administration

Body Weight at Time of DosingRecommended Dose
Less than 50 kg75 mg
Greater than or equal to 50 kg150 mg

Pediatric Patients 2 years and older: Recommended dosage is administered by subcutaneous injection at Weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter.        





Most viewed Cosentyx resources

Enroll in patient savings program
Coverage Authorization Request
Coverage Authorization Appeal
Complete Letter of Medical Necessity

drug label

Cosentyx prescribing information

Have more Cosentyx questions?

Submit MSL Request
Learn More

Need to report a Cosentyx issue?

ONLINE FORM
Report adverse event
Learn More

samples

Request Cosentyx samples

Online Sample Form ( Phone number)
Learn More

prior authorization

Cosentyx Prior authorization resources

Complete Letter of Medical Necessity
Coverage Authorization Request

NOT PROVIDED BY BRAND
Complete Coverage Authorization appeals
Coverage Authorization Appeal
Learn More

Benefits investigation

NOT PROVIDED BY BRAND
Benefits investigation resources
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Cosentyx Financial assistance options

Co-pay savings program

commercial only
Enroll in patient savings program
Enrollment & Prescription Form
Learn More

Bridge program

commercial only
Enroll in Bridge Program
Enrollment & Prescription Form
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Novartis Patient Assistance Foundation Application - English
Novartis Patient Assitance Foundation Application - Spanish
Enrollment & Prescription Form
Learn More

patient education

Cosentyx Patient education

Getting started on Cosentyx

Instructions For Use - 75mg Pre-filled Syringe : All Indications
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use - 150 mg Pre-filled Syringe: All Indications
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use - 150mg Sensoready Pen : All Indications
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Instructions For Use - 150 mg Sensoready Pen (Video): All Indications
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient toolkit

About Cosentyx - Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories - Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Plaque Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Cosentyx - Psoriatic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories - Psoriatic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources - Psoriatic Arthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Cosentyx - Non-radiographic Axial Spondyloarthritis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Cosentyx - Ankylosing Spondylitis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories - Ankylosing Spondylitis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Cosentyx - Pediatric Psoriasis
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Cosentyx FAQs

What is the risk of taking COSENTYX during pregnancy?Limited human data are available on the use of COSENTYX during pregnancy. The available data from an embryo-fetal development study in monkeys showed no adverse developmental effects in infants born to pregnant monkeys after subcutaneous administration of secukinumab during organogenesis at doses up to 30 times the maximum recommended human dose. However, the background risk of major birth defects and miscarriage in the indicated population is unknown.
Is COSENTYX safe to use while breastfeeding?It is not known whether secukinumab is excreted in human milk or absorbed systemically after ingestion. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for COSENTYX and any potential adverse effects on the breastfed child from COSENTYX or from the underlying maternal condition.
Can COSENTYX be used in pediatric patients?The safety and effectiveness of COSENTYX have been established in pediatric subjects aged 6 years and older with moderate to severe plaque psoriasis, as well as in patients weighing 15 kg or more with juvenile psoriatic arthritis (JPsA) aged 2 years and older and enthesitis-related arthritis (ERA) aged 4 years and older. However, the safety and effectiveness of COSENTYX in pediatric patients below the age of 6 years or with body weight less than 15 kg have not been established.
Is there any information on the use of COSENTYX in geriatric patients?Although no differences in safety or efficacy were observed between older and younger subjects in clinical trials, the number of subjects aged 65 years and older was not sufficient to determine whether they responded differently from younger subjects. Of the 3430 plaque psoriasis subjects exposed to COSENTYX in clinical trials, a total of 230 were 65 years or older, and 32 subjects were 75 years or older.
What is the maximum recommended human dose of COSENTYX?The maximum recommended human dose (MRHD) of COSENTYX is not specified in the information provided. However, in an embryo-fetal development study, no adverse developmental effects were observed in infants born to pregnant monkeys after subcutaneous administration of secukinumab during organogenesis at doses up to 30 times the MRHD.
FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.